148 related articles for article (PubMed ID: 37612257)
1. Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis.
Liu F; Wu Y; Zhang B; Yang S; Shang K; Li J; Zhang P; Deng W; Chen L; Zheng L; Gai X; Zhang H
Chin Med J (Engl); 2024 Jan; 137(2):181-189. PubMed ID: 37612257
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer.
Liu F; Gai X; Wu Y; Zhang B; Wu X; Cheng R; Tang B; Shang K; Zhao N; Deng W; Chen J; Zhang Z; Gu S; Zheng L; Zhang H
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2202157119. PubMed ID: 36122209
[No Abstract] [Full Text] [Related]
3. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
[TBL] [Abstract][Full Text] [Related]
4. Targeting the active beta-catenin pathway to treat cancer cells.
Dvory-Sobol H; Sagiv E; Kazanov D; Ben-Ze'ev A; Arber N
Mol Cancer Ther; 2006 Nov; 5(11):2861-71. PubMed ID: 17121933
[TBL] [Abstract][Full Text] [Related]
5. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.
Liang Y; Feng Y; Zong M; Wei XF; Lee J; Feng Y; Li H; Yang GS; Wu ZJ; Fu XD; Feng GS
Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.
Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572
[TBL] [Abstract][Full Text] [Related]
7. Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.
Loesch R; Caruso S; Paradis V; Godard C; Gougelet A; Renault G; Picard S; Tanaka I; Renoux-Martin Y; Perret C; Taketo MM; Zucman-Rossi J; Colnot S
J Hepatol; 2022 Aug; 77(2):424-435. PubMed ID: 35257829
[TBL] [Abstract][Full Text] [Related]
8. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
[TBL] [Abstract][Full Text] [Related]
9. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.
Tao J; Krutsenko Y; Moghe A; Singh S; Poddar M; Bell A; Oertel M; Singhi AD; Geller D; Chen X; Lujambio A; Liu S; Monga SP
Hepatology; 2021 Aug; 74(2):741-759. PubMed ID: 33529367
[TBL] [Abstract][Full Text] [Related]
11. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression.
Sun T; Zhang J
J Biochem; 2021 Dec; 170(5):663-673. PubMed ID: 34347084
[TBL] [Abstract][Full Text] [Related]
12. β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.
Senni N; Savall M; Cabrerizo Granados D; Alves-Guerra MC; Sartor C; Lagoutte I; Gougelet A; Terris B; Gilgenkrantz H; Perret C; Colnot S; Bossard P
Gut; 2019 Feb; 68(2):322-334. PubMed ID: 29650531
[TBL] [Abstract][Full Text] [Related]
13. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
Giera S; Braeuning A; Köhle C; Bursch W; Metzger U; Buchmann A; Schwarz M
Toxicol Sci; 2010 May; 115(1):22-33. PubMed ID: 20118494
[TBL] [Abstract][Full Text] [Related]
15. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.
Vivekanandan P; Torbenson M; Ramakrishna B
J Gastrointest Cancer; 2011 Mar; 42(1):20-5. PubMed ID: 20963515
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
18. β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in
Zou M; Al-Yahya S; Al-Alwan M; BinEssa HA; Khabar KSA; Almohanna F; Assiri AM; Altaweel A; Qattan A; Meyer BF; Alzahrani AS; Shi Y
Front Immunol; 2023; 14():1171816. PubMed ID: 37483610
[TBL] [Abstract][Full Text] [Related]
19. HGF/c-Met related activation of β-catenin in hepatoblastoma.
Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M
J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464
[TBL] [Abstract][Full Text] [Related]
20. Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice.
Braeuning A; Singh Y; Rignall B; Buchmann A; Hammad S; Othman A; von Recklinghausen I; Godoy P; Hoehme S; Drasdo D; Hengstler JG; Schwarz M
Histochem Cell Biol; 2010 Nov; 134(5):469-81. PubMed ID: 20886225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
